Frontier life technology sectors, represented by gene & cell science, anti-aging medicine and biotech skincare, continue to attract global capital, with fundraising hitting record highs.
Industry analysts attribute the acceleration to three factors: rising technology maturity, improving regulatory frameworks and exploding consumer demand. Companies with multi-dimensional capabilities across research, clinical and consumer markets will gain the advantage in the next stage of competition.
Dome Life will keep pursuing independent R&D together with open collaboration, moving frontier technology from the laboratory to large-scale application.
